Status:
TERMINATED
Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Lead Sponsor:
Centre Hospitalier de PAU
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether adjunction of intravenous anticoagulant therapy (enoxaparin, HNF, bivalirudin) to antiaggregation with clopidogrel and aspirin improves in-hospital re...
Detailed Description
* Background : We don't know if using IV anticoagulant therapy is necessary for percutaneous coronary angioplasty in stable patients. * Purpose : to compare efficacy and security of use or not of diff...
Eligibility Criteria
Inclusion
- stable angina pectoris or silent ischaemia
Exclusion
- instable angina or ACS (Acute Coronary Syndrome)
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 3 2013
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT00669149
Start Date
June 1 2008
End Date
August 3 2013
Last Update
May 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Pau
Pau, Pyrénées-Atlantiques, France, 64046